Dr. Lal PathLabs Statistics

Total Valuation

Dr. Lal PathLabs has a market cap or net worth of INR 243.62 billion. The enterprise value is 234.68 billion.

Market Cap	243.62B
Enterprise Value	234.68B

Important Dates

The next estimated earnings date is Wednesday, January 22, 2025.

Earnings Date	Jan 22, 2025
Ex-Dividend Date	Nov 5, 2024

Share Statistics

Dr. Lal PathLabs has 83.31 million shares outstanding. The number of shares has increased by 4.05% in one year.

Current Share Class	n/a
Shares Outstanding	83.31M
Shares Change (YoY)	+4.05%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	55.32%
Owned by Institutions (%)	28.40%
Float	36.98M

Valuation Ratios

The trailing PE ratio is 63.01 and the forward PE ratio is 50.28. Dr. Lal PathLabs's PEG ratio is 3.00.

PE Ratio	63.01
Forward PE	50.28
PS Ratio	10.37
PB Ratio	12.16
P/TBV Ratio	20.75
P/FCF Ratio	48.73
P/OCF Ratio	n/a
PEG Ratio	3.00

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.92, with an EV/FCF ratio of 46.94.

EV / Earnings	58.46
EV / Sales	10.00
EV / EBITDA	35.92
EV / EBIT	45.34
EV / FCF	46.94

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.10.

Current Ratio	2.87
Quick Ratio	2.63
Debt / Equity	0.10
Debt / EBITDA	0.30
Debt / FCF	0.40
Interest Coverage	20.25

Financial Efficiency

Return on equity (ROE) is 21.17% and return on invested capital (ROIC) is 14.91%.

Return on Equity (ROE)	21.17%
Return on Assets (ROA)	12.83%
Return on Capital (ROIC)	14.91%
Revenue Per Employee	5.72M
Profits Per Employee	979,349
Employee Count	4,099
Asset Turnover	0.93
Inventory Turnover	22.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.62% in the last 52 weeks. The beta is 0.30, so Dr. Lal PathLabs's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+12.62%
50-Day Moving Average	3,085.54
200-Day Moving Average	2,895.50
Relative Strength Index (RSI)	38.17
Average Volume (20 Days)	152,555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Lal PathLabs had revenue of INR 23.46 billion and earned 4.01 billion in profits. Earnings per share was 46.41.

Revenue	23.46B
Gross Profit	13.57B
Operating Income	5.18B
Pretax Income	5.69B
Net Income	4.01B
EBITDA	6.16B
EBIT	5.18B
Earnings Per Share (EPS)	46.41

Full Income Statement

Balance Sheet

The company has 11.27 billion in cash and 1.99 billion in debt, giving a net cash position of 9.28 billion or 111.41 per share.

Cash & Cash Equivalents	11.27B
Total Debt	1.99B
Net Cash	9.28B
Net Cash Per Share	111.41
Equity (Book Value)	20.35B
Book Value Per Share	240.44
Working Capital	8.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.37 billion and capital expenditures -365.67 million, giving a free cash flow of 5.00 billion.

Operating Cash Flow	5.37B
Capital Expenditures	-365.67M
Free Cash Flow	5.00B
FCF Per Share	60.01

Full Cash Flow Statement

Margins

Gross margin is 57.84%, with operating and profit margins of 22.06% and 17.11%.

Gross Margin	57.84%
Operating Margin	22.06%
Pretax Margin	24.24%
Profit Margin	17.11%
EBITDA Margin	26.24%
EBIT Margin	22.06%
FCF Margin	21.31%

Dividends & Yields

This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 0.62%.

Dividend Per Share	18.00
Dividend Yield	0.62%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	50.69%
Buyback Yield	-4.05%
Shareholder Yield	-3.43%
Earnings Yield	1.59%
FCF Yield	2.05%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a